Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis

Scand J Gastroenterol. 1996 Aug;31(8):818-24. doi: 10.3109/00365529609010359.

Abstract

Background: The accuracy of serum trypsinogen-2 in predicting the severity of acute necrotizing pancreatitis (ANP) was prospectively evaluated in 52 consecutive patients.

Methods: A new sensitive immunofluorometric assay was used for serum trypsinogen-2,

Results: Mean values during the first 24 h were 42.1 micrograms/l in control patients, 1435 micrograms/l in uncomplicated cases, and 4090 micrograms/l in complicated or fatal cases. There was a significant difference in serum trypsinogen-2 values between patients with uncomplicated and complicated disease (p = 0.002) already on admission. When a cutoff level of 1000 micrograms/l was used, patients with uncomplicated ANP were differentiated from patients with complicated ANP with a sensitivity of 91% and with a specificity of 71%.

Conclusions: The immunofluorometric assay of serum trypsinogen-2 is a sensitive and specific method for prediction of the severity of the disease in necrotizing pancreatitis.

MeSH terms

  • Adult
  • Aged
  • Amylases / blood
  • Amylases / urine
  • Biomarkers / blood
  • Biomarkers / urine
  • C-Reactive Protein / analysis
  • Female
  • Fluoroimmunoassay
  • Humans
  • Male
  • Middle Aged
  • Pancreatitis, Acute Necrotizing / blood*
  • Pancreatitis, Acute Necrotizing / diagnostic imaging
  • Pancreatitis, Acute Necrotizing / physiopathology
  • Pancreatitis, Acute Necrotizing / therapy
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed
  • Trypsin*
  • Trypsinogen / blood*
  • Trypsinogen / urine

Substances

  • Biomarkers
  • PRSS2 protein, human
  • Trypsinogen
  • C-Reactive Protein
  • Amylases
  • Trypsin